Search Clinical Trials
By Condition
By Location (USA)
By Location (Other)
By Sponsor
Resources
Privacy Policy
About Us
Disclaimer
Investigational Drug versus Amphotericin B for Empirical Therapy in Febrile, Neutropenic Pediatric Patients Clinical Trials Information presented on Clinical Trials Search is not intended to be a substitute for qualified health advice, trips or treatment by using a genuine doctor. We aren't doctors. Always consult your mD on Investigational Drug versus Amphotericin B for Empirical Therapy in Febrile, Neutropenic Pediatric Patients conditions. Clinical Trials Search.org is a site committed to listing clinical research studies in human subjects. Investigational Drug versus Amphotericin B for Empirical Therapy in Febrile, Neutropenic Pediatric Patients Clinical research trials and Investigational Drug versus Amphotericin B for Empirical Therapy in Febrile, Neutropenic Pediatric Patients health trials take place in a lot of of cities across the US. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally measure the potency of new drugs. The aim of the studies / projects is to answer specific human medical questions. Clinical trials are a popular manner for physicians, government agencies, and private sector corporations to discover remedies for all kinds of circumstances, like Investigational Drug versus Amphotericin B for Empirical Therapy in Febrile, Neutropenic Pediatric Patients. Investigational Drug versus Amphotericin B for Empirical Therapy in Febrile, Neutropenic Pediatric Patients Clinical Trials and other clinical trials allow for volunteers to have health treatment alternatives before they are available to the general public. Many times the test subjects obtain treatment for without cost, and occasionally they are paid for their time. Sometimes there is a cost for a Investigational Drug versus Amphotericin B for Empirical Therapy in Febrile, Neutropenic Pediatric Patients clinical trial. Subjects oftentimes recieve the most effective healthcare possible for their Investigational Drug versus Amphotericin B for Empirical Therapy in Febrile, Neutropenic Pediatric Patients condition. Hazards are a reality, however, and could include additional or frequent doctor visits, healthcare dangers (perhaps life-threatening), and/or the treatment being ineffective. Trials are federally governed with exacting guidelines to protect clinical trials subjects.

Home > "I" Clinical Trials Conditions > Investigational Drug versus Amphotericin B for Empirical Therapy in Febrile, Neutropenic Pediatric Patients

Investigational Drug versus Amphotericin B for Empirical Therapy in Febrile, Neutropenic Pediatric Patients



Investigational Drug versus Amphotericin B for Empirical Therapy in Febrile, Neutropenic Pediatric Patients

For Condition: Fever,Neutropenia
Status: Not yet recruiting
Sponsor(s): Sponsor Name Pending ,
Synopsis: This study is a double-blind, randomized study of the investigational agent versus liposomal amphotericin B in the empirical treatment of pediatric patients (ages 2 through 17 years) who have an absolute neutrophil count (ANC) below 500/microliter and who have fever despite broad antibiotic coverage. Such patients would be candidates for empirical therapy with an intravenous anti-fungal agent.
Details:
Eligibility:
Study Type:
  Interventional, Treatment, Randomized, Double-Blind, Active Control, Single Group Assignment, Safety Study
Minimum Age/Maximum Age: 2 Years/17 Years
Genders: Both
Protocol Entry Criteria: Inclusion Criteria: - Patients who are 17 years of age - Absolute Neutrophil Count (ANC) is below 500/microliter - Have persistent fever (at least 4 days) despite antibiotic therapy
Total Enrollment: 

Location and Contact Information:


Additional Information:
Study ID Numbers:
  0404ETPP; 
Study Start Date: 
Record last reviewed: May 2004
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00082537

Other Fever Studies:
1. Phase I Study of the Safety, Tolerance, and Pharmacokinetics of FK463 in Immunocompromised Children with Fever and Neutropenia

2. Investigational Drug versus Amphotericin B for Empirical Therapy in Febrile, Neutropenic Pediatric Patients

3. A Prospective, Randomized, Phase III Trial of FLAC (5-Fluorouracil, Leucovorin, Adriamycin, Cytoxan) Chemotherapy with GM-CSF (Granulocyte-Macrophage Colony-Stimulating Factor) Versus PIXY 321 in Advanced Breast Cancer

4. Investigating Anidulafungin in Children with Fever and Neutropenia

5. Treatment of neutropenic patients with fever who are suspected to have a gram positive infection (a specific kind of bacteria)

Related Studies:

Other Fever Clinical Trials
Other Clinical Trials
Other Clinical Trials

Investigational Drug versus Amphotericin B for Empirical Therapy in Febrile, Neutropenic Pediatric Patients

Modify your Search

  Other Fever Clinical Trials
  Other Clinical Trials
  Other Clinical Trials


Warning: include(/var/www/cgi-bin/traxis/counter.php) [function.include]: failed to open stream: No such file or directory in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103

Warning: include() [function.include]: Failed opening '/var/www/cgi-bin/traxis/counter.php' for inclusion (include_path='.:/usr/local/lib/php') in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103